Skip to Content
Merck
CN
  • Aqueous extract of Rosmarinus officinalis L. inhibits neutrophil influx and cytokine secretion.

Aqueous extract of Rosmarinus officinalis L. inhibits neutrophil influx and cytokine secretion.

Phytotherapy research : PTR (2014-10-17)
Ana Mara de Oliveira E Silva, Isabel Daufenback Machado, José Roberto Santin, Illana Louise Pereira de Melo, Gabriela Vieira Pedrosa, Maria Ines Genovese, Sandra Helena Poliselli Farsky, Jorge Mancini-Filho
ABSTRACT

Rosmarinus officinalis L. phenolic compounds have attracted considerable attention because of their antioxidant and antimicrobial properties, including its ability to treat inflammatory disorders. In this work, we investigated the in vivo and in vitro effects of R. officinalis aqueous extract on neutrophil trafficking from the blood into an inflamed tissue, on cell-derived secretion of chemical mediators, and on oxidative stress. Anti-inflammatory activity was investigated using carrageenan-induced inflammation in the subcutaneous tissue of male Wistar rats orally treated with the R. officinalis extract (100, 200, or 400 mg/kg). The leukocyte influx (optical microscopy), secretion of chemical mediators (prostaglandin E2 (PGE2), TNF-α, interleukin 6 (IL-6), leukotriene B4 (LTB4), and cytokine-induced neutrophil chemoattractant 1 by enzyme-linked immunosorbent assay), and the anti-oxidative profile (super oxide dismutase (SOD), glutathione peroxidase, and thiobarbituric acid reactive substance (TBARS) spectrophotometry) were quantified in the inflamed exudate. N-Formyl-methionine-leucine-phenylalanine-induced chemotaxis, lipopolysaccharide-induced NO2 (-) production (Greiss reaction), and adhesion molecule expression (flow cytometry) were in vitro quantified using oyster glycogen recruited peritoneal neutrophils previous treated with the extract (1, 10, or 100 µg/mL). Animals orally treated with phosphate-buffered saline and neutrophils incubated with Hank's balanced salt solution were used as control. R. officinalis extract oral treatment caused a dose-dependent reduction in the neutrophil migration as well as decreased SOD, TBARS, LTB4, PGE2, IL-6, and TNF-α levels in the inflamed exudate. In vitro treatment with R. officinalis decreased neutrophil chemotaxis, NO2 (-) production, and shedding of L-selectin and β2 integrin expressions. Results here presented show that R. officinalis aqueous extract displays important in vivo and in vitro anti-inflammatory actions by blocking pathways of neutrophil migration and secretion, suggesting its therapeutic application to acute inflammatory reactions.

MATERIALS
Product Number
Brand
Product Description

Supelco
Sulfanilamide melting point standard, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Rosmarinic acid, 96%
Rosmarinic acid, primary reference standard
Supelco
Apigenin, analytical standard
Sigma-Aldrich
N-(1-Naphthyl)ethylenediamine dihydrochloride, ACS reagent, >98%
USP
Sulfanilamide Melting Point Standard, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Sulfanilamide, puriss. p.a., ≥98% (calc. to the dried substance)
Sigma-Aldrich
Propidium iodide, ≥94% (HPLC)
Supelco
N-(1-Naphthyl)ethylenediamine dihydrochloride, ACS reagent, ≥98%
Sigma-Aldrich
Apigenin, ≥95.0% (HPLC)
Supelco
Sulfanilamide, VETRANAL®, analytical standard
Sigma-Aldrich
Prostaglandin E2, synthetic, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Indomethacin, 98.0-102.0%, meets EP testing specifications
Sigma-Aldrich
Prostaglandin E2, ≥93% (HPLC), synthetic
Sigma-Aldrich
Indomethacin, meets USP testing specifications
Sigma-Aldrich
Prostaglandin E2, γ-irradiated, powder, BioXtra, suitable for cell culture
Sigma-Aldrich
N-(1-Naphthyl)ethylenediamine dihydrochloride, ≥98%
Sigma-Aldrich
Leukotriene B4, ≥97%
Sigma-Aldrich
Propidium iodide, ≥94.0% (HPLC)
Indomethacin, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Sulfanilamide, ≥98%
Rosmarinic acid, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Rosmarinic acid, ≥98% (HPLC), from Rosemarinus officinalis L.
USP
Sulfanilamide, United States Pharmacopeia (USP) Reference Standard
Sulfanilamide, European Pharmacopoeia (EP) Reference Standard
Supelco
Indomethacin, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Indomethacin, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Ethylenediaminetetraacetic acid solution, 0.02% in DPBS (0.5 mM), sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
N-Formyl-Met-Leu-Phe, ≥97% (HPLC)
Sigma-Aldrich
Ethylenediaminetetraacetic acid, anhydrous, crystalline, BioReagent, suitable for cell culture